ARTICLE | Clinical News
Japan approves stem cell product for spinal cord injury
January 25, 2019 8:05 PM UTC
Japan's Ministry of Health, Labour and Welfare (MHLW) granted conditional approval in December to Stemirac, an autologous bone marrow-derived mesenchymal stem cell product to treat spinal cord injury (SCI) that was jointly developed by Nipro Corp. (Tokyo:8086) and Sapporo Medical University (Sapporo, Japan)...